Increased Resistance of LFA-1-deficient Mice to Lipopolysaccharide-induced Shock/liver Injury in the Presence of TNF-alpha and IL-12 is Mediated by IL-10: a Novel Role for LFA-1 in the Regulation of the Proinflammatory and Anti-inflammatory Cytokine...
Overview
Authors
Affiliations
Challenge with low doses of LPS together with D-galactosamine causes severe liver injury, resulting in lethal shock (low dose LPS-induced shock). We examined the role of LFA-1 in low dose LPS-induced shock. LFA-1(-/-) mice were more resistant to low dose LPS-induced shock/liver injury than their heterozygous littermates, although serum levels of TNF-alpha and IL-12 were higher in these mice. C57BL/6 mice were not rescued from lethal effects of LPS by depletion of NK1(+) cells, granulocytes, or macrophages, and susceptibility of NKT cell-deficient mice was comparable to that of controls. High numbers of platelets were detected in the liver of LFA-1(+/-) mice after low dose LPS challenge, whereas liver accumulation of platelets was only marginal in LFA-1(-/-) mice. Following low dose LPS challenge, serum levels of IL-10 were higher in LFA-1(-/-) mice than in LFA-1(+/-) mice, and susceptibility to low dose LPS-induced shock as well as platelet accumulation in the liver of LFA-1(-/-) mice were markedly increased by IL-10 neutralization. Serum levels of IL-10 in LFA-1(+/-) mice were only marginally affected by macrophage depletion. However, in LFA-1(-/-) mice macrophage depletion markedly reduced serum levels of IL-10, and as a corollary, susceptibility of LFA-1(-/-) mice to low dose LPS-induced shock was markedly elevated despite the fact that TNF-alpha levels were also diminished. We conclude that LFA-1 participates in LPS-induced lethal shock/liver injury by regulating IL-10 secretion from macrophages and that IL-10 plays a decisive role in resistance to shock/liver injury. Our data point to a novel role of LFA-1 in control of the proinflammatory/anti-inflammatory cytokine network.
Molecular Targets in Infections.
Heimesaat M, Backert S, Alter T, Bereswill S Biomolecules. 2023; 13(3).
PMID: 36979344 PMC: 10046527. DOI: 10.3390/biom13030409.
Mousavi S, Bereswill S, Heimesaat M Curr Top Microbiol Immunol. 2021; 431:233-263.
PMID: 33620654 DOI: 10.1007/978-3-030-65481-8_9.
Human Campylobacteriosis-A Serious Infectious Threat in a One Health Perspective.
Heimesaat M, Backert S, Alter T, Bereswill S Curr Top Microbiol Immunol. 2021; 431:1-23.
PMID: 33620646 DOI: 10.1007/978-3-030-65481-8_1.
Bailey W, Cui K, Ardell C, Keever K, Singh S, Rodriguez-Gil D J Leukoc Biol. 2021; 109(5):877-890.
PMID: 33438263 PMC: 8085079. DOI: 10.1002/JLB.3HI0820-529RR.
Extracellular gp96 is a crucial mediator for driving immune hyperactivation and liver damage.
Guan Z, Ding Y, Liu Y, Zhang Y, Zhao J, Li C Sci Rep. 2020; 10(1):12596.
PMID: 32724151 PMC: 7387550. DOI: 10.1038/s41598-020-69517-7.